{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:27:50Z","timestamp":1772310470405,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00701-015-2519-0","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T03:41:29Z","timestamp":1438746089000},"page":"1731-1740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic factors of craniopharyngioma with special reference to autocrine\/paracrine signaling: underestimated implication of growth hormone receptor"],"prefix":"10.1007","volume":"157","author":[{"given":"Yoshikazu","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"2519_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/01913120500408018","volume":"30","author":"L Agozzino","year":"2006","unstructured":"Agozzino L, Ferraraccio F, Accardo M, Esposito S, Agozzino M, Cuccurullo L (2006) Morphological and ultrastructural findings of prognostic impact in craniopharyngiomas. Ultrastruct Pathol 30:143\u2013150","journal-title":"Ultrastruct Pathol"},{"key":"2519_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2478\/raon-2013-0036","volume":"47","author":"R Bonsnjak","year":"2013","unstructured":"Bonsnjak R, Benedicic M, Vittori A (2013) Early outcome in endoscopic extended endonasal approach for removal of supradiaphragmatic craniopharyngiomas: a case series and a comprehensive review. Radiol Oncol 47:266\u2013279","journal-title":"Radiol Oncol"},{"key":"2519_CR3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1440-1789.2008.00986.x","volume":"29","author":"A Boongrid","year":"2009","unstructured":"Boongrid A, Laothamatas J, Larbcharoensub N, Phudhichareonrat S (2009) Malignant craniopharyngioma; case report and review of the literature. Neuropathology 29:591\u2013596","journal-title":"Neuropathology"},{"key":"2519_CR4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3171\/2009.2.JNS081026","volume":"111","author":"LM Cavallo","year":"2009","unstructured":"Cavallo LM, Prevedello DM, Solari D, Gardner PA, Esposito F, Snyderman CH, Carrau RL, Kassam AB, Cappabianca P (2009) Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas. J Neurosurg 111:578\u2013589","journal-title":"J Neurosurg"},{"key":"2519_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10143-012-0403-4","volume":"36","author":"LM Cavallo","year":"2013","unstructured":"Cavallo LM, Solari D, Esposito F, Cappabianca P (2013) The endoscopic endonasal approach for the management of craniopharyngiomas involving the third ventricle. Neurosurg Rev 36:27\u201338","journal-title":"Neurosurg Rev"},{"key":"2519_CR6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/jcp.2007.050666","volume":"61","author":"CY Chai","year":"2008","unstructured":"Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH (2008) Hypoxia-inducible factor-1 alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavorable prognosis in urothelial carcinoma. J Clin Pathol 61:658\u2013664","journal-title":"J Clin Pathol"},{"key":"2519_CR7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","volume":"63","author":"TT Chung","year":"2005","unstructured":"Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL, Grossman AB, Besser GM, Monson JP (2005) Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. Clin Endocrinol (Oxf) 63:274\u2013279","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2519_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1227\/01.NEU.0000134287.19377.A2","volume":"55","author":"WT Couldwell","year":"2004","unstructured":"Couldwell WT, Weiss MH, Rabb C, Liu JK, Apfelbaum RI, Fukushima T (2004) Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases. Neurosurgery 55:539\u2013550","journal-title":"Neurosurgery"},{"key":"2519_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1227\/01.neu.0000303220.55393.73","volume":"61","author":"E Divitiis de","year":"2007","unstructured":"de Divitiis E, Cappabianka P, Cavallo LM, Esposito F, de Divitiis O, Messina A (2007) Extended endoscopic transsphenoidal approach for extrasellar craniopharyngiomas. Neurosurgery 61:219\u2013228","journal-title":"Neurosurgery"},{"key":"2519_CR10","first-page":"115","volume":"57","author":"D Duo","year":"2003","unstructured":"Duo D, Gasverde S, Benech F, Zenga F, Giordana MT (2003) MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis. Clin Neuropathol 57:115\u2013121","journal-title":"Clin Neuropathol"},{"key":"2519_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3171\/jns.1999.90.2.0237","volume":"90","author":"R Fahlbusch","year":"1999","unstructured":"Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237\u2013250","journal-title":"J Neurosurg"},{"key":"2519_CR12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000106070","volume":"71","author":"S Fukunaga","year":"2006","unstructured":"Fukunaga S, Maeda K, Noda E, Inoue T, Wada K, Hirakawa K (2006) Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer. Oncology 71:204\u2013211","journal-title":"Oncology"},{"key":"2519_CR13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1227\/01.NEU.0000372918.68453.5B","volume":"67","author":"BM Hofmann","year":"2010","unstructured":"Hofmann BM, Hoelsken A, Fahlbusch R, Blumcke I, Buslei R (2010) Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation. Neurosurgery 67:617\u2013625","journal-title":"Neurosurgery"},{"issue":"1 Suppl","key":"2519_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000120861","volume":"21","author":"HJ Hoffman","year":"1994","unstructured":"Hoffman HJ (1994) Surgical management of craniopharyngioma. Pediatr Neurosurg 21(1 Suppl):44\u201349","journal-title":"Pediatr Neurosurg"},{"key":"2519_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1464-410X.2004.04605.x","volume":"93","author":"J Jacobsen","year":"2004","unstructured":"Jacobsen J, Grankvist K, Rasmuson T, Bergh A, Landberg G, Ljungberg B (2004) Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int 93:297\u2013302","journal-title":"BJU Int"},{"key":"2519_CR16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/er.2006-0002","volume":"27","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki N, Cudlip S, Adams CBT, Wass JA (2006) Craniopharyngiomas. Endocr Rev 27:371\u2013397","journal-title":"Endocr Rev"},{"key":"2519_CR17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","volume":"64","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Aenold J, Turner HE, Wass AH (2006) GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf) 64:556\u2013560","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2519_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jocn.2012.04.014","volume":"20","author":"Q Li","year":"2013","unstructured":"Li Q, You C, Liu L, Rao Z, Sima X, Zhou L, Xu J (2013) Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R). J Clin Neurosci 20:153\u2013157","journal-title":"J Clin Neurosci"},{"key":"2519_CR19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/jnnp.2003.012781","volume":"75","author":"M Losa","year":"2004","unstructured":"Losa M, Vimercati A, Acerno S, Barzaghi RL, Mortini P, Mangili F, Terreni MR, Santambrogio G, Giovanelli M (2004) Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry 75:889\u2013892","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2519_CR20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3171\/2010.11.JNS10670","volume":"114","author":"P Mortini","year":"2011","unstructured":"Mortini P, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, Angius D, Weber G, Chiumello G, Giovanelli M (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 114:1350\u20131359","journal-title":"J Neurosurg"},{"key":"2519_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000284358","volume":"73","author":"HJ Muller","year":"2008","unstructured":"Muller HJ, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Mets M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sorensen N (2008) Analyses of treatment variables for patients with childhood craniopharyngioma\u2014results of the multicenter prospective trial Kraniopharyngiom 2000 after three years of follow-up. Horm Res Pediatr 73:175\u2013180","journal-title":"Horm Res Pediatr"},{"key":"2519_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clineuro.2014.07.014","volume":"125","author":"Y Ogawa","year":"2014","unstructured":"Ogawa Y, Kawaguchi T, Tominaga T (2014) Outcomes and mid-term prognosis after maximum and radical removal of craniopharyngiomas with the priority to the extended transsphenoidal approach\u2014a single center experience. Clin Neurol Neurosurg 125:41\u201346","journal-title":"Clin Neurol Neurosurg"},{"key":"2519_CR23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12022-014-9328-5","volume":"25","author":"Y Ogawa","year":"2014","unstructured":"Ogawa Y, Watanabe M, Tominaga T (2014) Spontaneous alteration from Rathke\u2019s cleft cyst to craniopharyngioma\u2014possible involvement of transformation between these pathologies. Endocr Pathol 25:422\u2013426","journal-title":"Endocr Pathol"},{"key":"2519_CR24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1530\/EJE-12-0077","volume":"166","author":"DS Olsson","year":"2012","unstructured":"Olsson DS, Buchfelder M, Wiendieck K, Kremenevskaja N, Bengtsson BA, Jakobsson KE, Jarfelt M, Johannsson G, Nilsson AG (2012) Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up. Eur J Endocrinol 166:1061\u20131068","journal-title":"Eur J Endocrinol"},{"key":"2519_CR25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.wneu.2012.07.033","volume":"79","author":"R Prieto","year":"2013","unstructured":"Prieto R, Pascual JM, Subhin-Issa I, Jorquera M, Ysu M, Martinez R (2013) Predictive factors for craniopharyngioma recurrence: a systemic review and illustrative case report of a rapid recurrence. World Neurosurg 79:733\u2013749","journal-title":"World Neurosurg"},{"issue":"1 Suppl","key":"2519_CR26","first-page":"3","volume":"106","author":"S Puget","year":"2007","unstructured":"Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3\u201312","journal-title":"J Neurosurg"},{"key":"2519_CR27","doi-asserted-by":"crossref","unstructured":"Shen L, Sun CM, Li XT, Liu CJ, Zhou YX (2015) Growth hormone therapy and risk of recurrence\/progression in intracranial tumors: a meta-analysis. Neurol Sci 6 (Epub ahead of print)","DOI":"10.1007\/s10072-015-2269-z"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-015-2519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-015-2519-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-015-2519-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T22:30:55Z","timestamp":1567031455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-015-2519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1007\/s00701-015-2519-0","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]}}}